PROJECT

Papers of the Month - Nov 99

  • To return to the home page, click here
    
    Note to the reader:  For a while I have been trying to put up
    direct pointers to the referenced papers, but unfortunately
    they move around and the links often fail to work.  Accordingly,
    I am going back to the old format.  To retreive the abstract or
    order a copy of the paper, the reader may always search one
    or more of the authors, or a title keyword, on MedLine.  There
    is a pointer to MedLine at the bottom of my homepage.
    
    #1.  Dobrin PB.  Animal models of aneurysms.  Annals of
    Vascular Surgery 1999; 13: 641-648.
    
    Comment by mdt: This comprehensive reference is highly
    recommended for laboratory workers interested in the problem
    of aneurysms.  Dobrin has made pioneering contributions of
    his own toward the development of the elastase-infusion
    model (in collaboration with Anidjar), and among all of the
    animal models, this one is perhaps the most informative.
    
    #2.  Lawrence PF, et al.  THe epidemiology of surgically 
    repaired aneurysms in the United States.  J Vasc Surg
    1999; 30: 632-40.
    
    Comment by mdt: Lawrence and colleagues have prepared
    an extensive report based on data collected from the 
    National Hospital Discharge Survey, which is a 
    comprehensive database of patients hospitalized in
    non-federal acute-care hospitals in the USA.  In 1994
    there were 51,949 non-cerebral aneurysm repairs in
    the USA.  Seventy-five % (about 39,000) were for AAA.
    Operative mortalities were 8.4% for elective, and 68%
    for emergency repair.  The reader is referred to the source
    for additional interesting detail re effects of geographical
    distribution and hospital size.
    
    #3.  Hirose H, Tilson MD.  Negative genetic risk factor
    for AAA: HLA-DQ3, a Japanese study.  J Vasc Surg
    1999; 30: 959.
    
    Comment by mdt: This brief communication was a letter
    to the Editor of the JVS regarding a followup finding
    among the AAA patients previously reported.  The 
    initial report suggested that HLA-DR 15 was a positive
    risk factor; and the present report suggests that
    HLA-DQ3 is a negative risk factor.  Altogether, 89%
    of 36 patients were either DR15 positive or DRQ3
    negative.  It remains to be seen whether these genes
    have etiologic significance in AAA disease or whether
    they are markers for the presence of other pathogenetic
    genes.  It also remains to be seen whether the
    effects are independent or due to linkage disequilibrium.
    Finally, it remains to be seen whether findings in
    the relatively homogeneous population of Japan will
    apply to the more mixed population of North America.